The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
NCT00271622
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Neurologic Disorders
- Autism
- Neurodegenerative Disease
- Neurobehavioral Manifestation
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 6 weeks and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Institute of Mental Health (NIMH)
- Last updated on ClinicalTrials.gov
- September 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.